[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338492-105":59,"doc-detail-338492-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","targeting-squalene-epoxidase-in-the-treatment-of-metabolic-related-diseases-current-research-and-future-directions","Targeting squalene epoxidase in the treatment of metabolic-related diseases - current research and future directions","","Metabolic-related diseases are chronic, multifactorial conditions shaped by genetics and environment, with limited cures and serious impacts on health. Squalene epoxidase (SQLE), a second rate-limiting enzyme in cholesterol synthesis, influences cholesterol production and affects gut microbiota and tumor immunity. SQLE is expressed across tissues and contributes to cancer, nonalcoholic fatty liver disease, diabetes mellitus, and obesity. The review summarizes current SQLE-focused research and highlights SQLE expression regulation as a key direction for developing pharmacologically effective therapies.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/targeting-squalene-epoxidase-in-the-treatment-of-metabolic-related-diseases-current-research-and-future-directions/338492/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/targeting-squalene-epoxidase-in-the-treatment-of-metabolic-related-diseases-current-research-and-future-directions/338492.png","ImageObject",300,407,{"name":92,"@type":93},"Evangeline","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What role does squalene epoxidase (SQLE) play in metabolic-related diseases?","Question",{"text":113,"@type":114},"SQLE is the second rate-limiting enzyme in cholesterol synthesis and helps regulate cholesterol biosynthesis. It also alters gut microbiota and tumor immunity, contributing to multiple metabolic-related diseases such as cancer, NAFLD, diabetes mellitus, and obesity.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Why is SQLE considered a potential therapeutic target?",{"text":118,"@type":114},"The review explains that understanding SQLE’s precise role in disease pathogenesis and its underlying regulatory mechanisms can support effective preventive and therapeutic strategy development. Targeting SQLE expression and activity is presented as important for future drug development.",{"name":120,"@type":111,"acceptedAnswer":121},"Which SQLE inhibitors are mentioned, and what effects are reported?",{"text":122,"@type":114},"Examples include terbinafine, NB598, natural compounds, and their derivatives. These inhibitors are reported to effectively ameliorate fungal infections, nonalcoholic fatty liver disease, and cancer.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},338492,1790216200,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":26,"preview_page_count":81,"preview_urls":146},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","Submitted 18 July 2024  \nAccepted 23 October 2024 Published 22 November 2024  \nCorresponding author  \nLian Du, [dulian@cdutcm.edu.cn](dulian@cdutcm.edu.cn)[ ](dulian@cdutcm.edu.cn)Academic editor  \nNing Li  \nAdditional Information and Declarations can be found on page 17  \nDOI 10.7717/peerj.18522  \nCopyright 2024 Chen et al.  \nDistributed under  \nCreative Commons CC-BY 4.0  \nTargeting squalene epoxidase in the treatment of metabolic-related diseases:  \ncurrent research and future directions  \nMingzhu Chen 1, Yongqi Yang2, Shiting Chen 1, Zhigang He 1 and Lian Du 1  \n1 School of Basic Medical Sciences, Chengdu University of Chinese Medicine, Chengdu, Sichuan Province, China  \n2 Harbin Medical University, Department of Pharmacology, College of Pharmacy, Harbin, Heilongjiang Province, China  \nABSTRACT  \nMetabolic-related diseases are chronic diseases caused by multiple factors, such as genetics and the environment. These diseases are difﬁcult to cure and seriously affect human health. Squalene epoxidase (SQLE), the second rate-limiting enzyme in cholesterol synthesis, plays an important role in cholesterol synthesis and alters the gut microbiota and tumor immunity. Research has shown that SQLE is expressed in many tissues and organs and is involved in the occurrence and development of various metabolic-related diseases, such as cancer, nonalcoholic fatty liver disease, diabetes mellitus, and obesity. SQLE inhibitors, such as terbinaﬁne, NB598, natural compounds, and their derivatives, can effectively ameliorate fungal infections, nonalcoholic fatty liver disease, and cancer. In this review, we provide an overview of recent research progress on the role of SQLE in metabolic-related diseases. Further research on the regulation of SQLE expression is highly important for developing drugs for the treatment of metabolic-related diseases with good pharmacological activity.  \nSubjects Diabetes and Endocrinology, Oncology, Obesity  \nKeywords SQLE, Metabolism, Cancer, Drug targets, Cholesterol synthesis, Nonalcoholic fatty liver disease, Diabetes mellitus, Obesity, SQLE inhibitors  \nINTRODUCTION  \nRapid economic growth, coupled with changes in people’s dietary habits and lifestyles, has led to surges in mortality and morbidity associated with metabolism-related diseases, placing a substantial burden on public health systems and medical resources (Saklayen, 2018) . The currently available medications for the prevention and treatment of these diseases require long-term use, and there are issues of general efﬁcacy, drug resistance, and adverse side effects. Therefore, the exploration of innovative approaches to prevent and control these conditions is important. Studies have identiﬁed squalene epoxidase (SQLE) as a key regulator of various physiological processes, including cholesterol biosynthesis (Parris et al., 2014; Padyana et al., 2019), modulation of the gut microbiota (Li et al., 2022a), and the regulation of tumor immunity (You et al., 2022) . Consequently, the involvement of SQLE has been implicated in the development of various conditions, such  \nHow to cite this article Chen M, Yang Y, Chen S, He Z, Du L. 2024. Targeting squalene epoxidase in the treatment of metabolic-related diseases: current research and future directions. PeerJ 12:e18522 DOI 10.7717/peerj.18522  \nas fungal infections (Ryder, 1992), nonalcoholic fatty liver disease (NAFLD) (Liu et al., 2021), cancer (Zhang et al., 2024), diabetes mellitus (DM) (Ge et al., 2020), and obesity (Ding et al., 2015) . Understanding the precise role of SQLE in the pathogenesis of these diseases and its potential as a therapeutic target is essential for devising effective preventive and therapeutic strategies. By elucidating the regulatory mechanisms and molecular pathways mediated by SQLE in metabolism-related diseases, we can establish a solid theoretical foundation for developing targeted interventions. Here, we aim to provide a comprehensive overview of SQLE, beginning with its struc","cbCaiixjH6tIoFW1","https://ap.wps.com/l/cbCaiixjH6tIoFW1","pdf",4106471,24,"English","# Abstract\n# Introduction\n# Intended audience and need for this review\n# Survey methodology\n# Structure, activity regulation, and function of SQLE\n## Structure of SQLE","[{\"question\":\"What role does squalene epoxidase (SQLE) play in metabolic-related diseases?\",\"answer\":\"SQLE is the second rate-limiting enzyme in cholesterol synthesis and helps regulate cholesterol biosynthesis. It also alters gut microbiota and tumor immunity, contributing to multiple metabolic-related diseases such as cancer, NAFLD, diabetes mellitus, and obesity.\"},{\"question\":\"Why is SQLE considered a potential therapeutic target?\",\"answer\":\"The review explains that understanding SQLE’s precise role in disease pathogenesis and its underlying regulatory mechanisms can support effective preventive and therapeutic strategy development. Targeting SQLE expression and activity is presented as important for future drug development.\"},{\"question\":\"Which SQLE inhibitors are mentioned, and what effects are reported?\",\"answer\":\"Examples include terbinafine, NB598, natural compounds, and their derivatives. These inhibitors are reported to effectively ameliorate fungal infections, nonalcoholic fatty liver disease, and cancer.\"}]","Targeting squalene epoxidase in the treatment of metabolic-related diseases - current research and future directions | PDF",1790023849,[147,151,155],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/478b26333e534c24d69b47f964dfb65b.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/e3e9ee6b08b293f1d1006ed2686b042a.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/36f61816932207c40d55e9a6084d01b2.webp",981,1269]